Silverfin false false 31/12/2025 01/01/2025 31/12/2025 M Rosmarini 28/07/2022 L Tiberi 28/07/2022 09 June 2026 no description of principal activity 14261927 2025-12-31 14261927 bus:Director1 2025-12-31 14261927 bus:Director2 2025-12-31 14261927 2024-12-31 14261927 core:CurrentFinancialInstruments 2025-12-31 14261927 core:CurrentFinancialInstruments 2024-12-31 14261927 core:ShareCapital 2025-12-31 14261927 core:ShareCapital 2024-12-31 14261927 core:SharePremium 2025-12-31 14261927 core:SharePremium 2024-12-31 14261927 core:OtherCapitalReserve 2025-12-31 14261927 core:OtherCapitalReserve 2024-12-31 14261927 core:RetainedEarningsAccumulatedLosses 2025-12-31 14261927 core:RetainedEarningsAccumulatedLosses 2024-12-31 14261927 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2024-12-31 14261927 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2025-12-31 14261927 core:OtherPropertyPlantEquipment 2024-12-31 14261927 core:OtherPropertyPlantEquipment 2025-12-31 14261927 bus:OrdinaryShareClass1 2025-12-31 14261927 bus:OrdinaryShareClass2 2025-12-31 14261927 bus:OrdinaryShareClass3 2025-12-31 14261927 2025-01-01 2025-12-31 14261927 bus:FilletedAccounts 2025-01-01 2025-12-31 14261927 bus:SmallEntities 2025-01-01 2025-12-31 14261927 bus:AuditExemptWithAccountantsReport 2025-01-01 2025-12-31 14261927 bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 14261927 bus:Director1 2025-01-01 2025-12-31 14261927 bus:Director2 2025-01-01 2025-12-31 14261927 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2025-01-01 2025-12-31 14261927 core:OtherPropertyPlantEquipment core:TopRangeValue 2025-01-01 2025-12-31 14261927 2024-01-01 2024-12-31 14261927 core:OtherPropertyPlantEquipment 2025-01-01 2025-12-31 14261927 bus:OrdinaryShareClass1 2025-01-01 2025-12-31 14261927 bus:OrdinaryShareClass1 2024-01-01 2024-12-31 14261927 bus:OrdinaryShareClass2 2025-01-01 2025-12-31 14261927 bus:OrdinaryShareClass2 2024-01-01 2024-12-31 14261927 bus:OrdinaryShareClass3 2025-01-01 2025-12-31 14261927 bus:OrdinaryShareClass3 2024-01-01 2024-12-31 iso4217:GBP xbrli:pure xbrli:shares

Company No: 14261927 (England and Wales)

CRONO SAAS LTD

Unaudited Financial Statements
For the financial year ended 31 December 2025
Pages for filing with the registrar

CRONO SAAS LTD

Unaudited Financial Statements

For the financial year ended 31 December 2025

Contents

CRONO SAAS LTD

COMPANY INFORMATION

For the financial year ended 31 December 2025
CRONO SAAS LTD

COMPANY INFORMATION (continued)

For the financial year ended 31 December 2025
Directors M Rosmarini
L Tiberi
Registered office 2nd Floor 168 Shoreditch High Street
London
United Kingdom
Company number 14261927 (England and Wales)
CRONO SAAS LTD

BALANCE SHEET

As at 31 December 2025
CRONO SAAS LTD

BALANCE SHEET (continued)

As at 31 December 2025
Note 2025 2024
£ £
Fixed assets
Intangible assets 3 235,456 151,203
Tangible assets 4 1,337 1,315
Investments 5 8,610 8,610
245,403 161,128
Current assets
Debtors 6 21,073 32,462
Cash at bank and in hand 7 55,194 233,604
76,267 266,066
Creditors: amounts falling due within one year 8 ( 3,821) ( 3,499)
Net current assets 72,446 262,567
Total assets less current liabilities 317,849 423,695
Net assets 317,849 423,695
Capital and reserves
Called-up share capital 9 146 125
Share premium account 994,127 351,342
Other reserves 0 448,559
Profit and loss account ( 676,424 ) ( 376,331 )
Total shareholders' funds 317,849 423,695

For the financial year ending 31 December 2025 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of Crono SAAS Ltd (registered number: 14261927) were approved and authorised for issue by the Board of Directors on 09 June 2026. They were signed on its behalf by:

M Rosmarini
Director
CRONO SAAS LTD

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 December 2025
CRONO SAAS LTD

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 December 2025
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Crono SAAS Ltd (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is 2nd Floor 168 Shoreditch High Street, London, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Foreign currency

The Company's functional and presentational currency is GBP.

Transactions in foreign currencies are recorded at the rate of exchange at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies at the Balance Sheet date are reported at the rates of exchange prevailing at that date.

Exchange differences are recognised in the Profit and Loss Account in the period in which they arise except for exchange differences arising on gains or losses on non-monetary items which are recognised in the Statement of Comprehensive Income.

Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Turnover is recognised when the significant risks and rewards are considered to have been transferred to the customer.

Intangible assets

Intangible assets are stated at cost or valuation, net of amortisation and any provision for impairment. Amortisation is provided on all intangible assets at rates to write off the cost or valuation of each asset over its expected useful life as follows:

Development costs not amortised
Research and development

Research expenditure is written off as incurred. Development expenditure is also written off, except where the directors are satisfied as to the technical, commercial and financial viability of individual projects. In such cases, the identifiable expenditure is capitalised as an intangible asset and amortised over the period during which the Company is expected to benefit. This period is between three and five years. Provision is made for any impairment.

Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line or reducing balance basis over its expected useful life, as follows:

Plant and machinery etc. 5 years straight line

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Impairment of assets

Assets, other than those measured at fair value, are assessed for indicators of impairment at each Balance Sheet date. If there is objective evidence of impairment, an impairment loss is recognised in the Profit and Loss Account as described below.

Trade and other debtors

Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts, except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in creditors: amounts falling due within one year.

Trade and other creditors

Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.

Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Financial assets are derecognised when and only when the contractual rights to the cash flows from the financial asset expire or are settled, or the Company transfers to another party substantially all of the risks and rewards of ownership of the financial asset, or the Company, despite having retained some, but not all, significant risks and rewards of ownership, has transferred control of the asset to another party.

Basic financial liabilities
Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Financial liabilities are derecognised when the Company's contractual obligations expire or are discharged or cancelled.

Valuation of investments

Investments in subsidiaries are measured at cost less accumulated impairment.

Investments in unlisted Company shares, whose market value can be reliably determined, are remeasured to market value at each balance sheet date. Gains and losses on remeasurement are recognised in the Profit and loss account for the period. Where market value cannot be reliably determined, such investments are stated at historic cost less impairment.

Investments in listed company shares are remeasured to market value at each balance sheet date. Gains and losses on remeasurement are recognised in profit or loss for the period.

2. Employees

2025 2024
Number Number
Monthly average number of persons employed by the Company during the year, including directors 0 0

3. Intangible assets

Development costs Total
£ £
Cost
At 01 January 2025 151,203 151,203
Additions 84,253 84,253
At 31 December 2025 235,456 235,456
Accumulated amortisation
At 01 January 2025 0 0
At 31 December 2025 0 0
Net book value
At 31 December 2025 235,456 235,456
At 31 December 2024 151,203 151,203

4. Tangible assets

Plant and machinery etc. Total
£ £
Cost
At 01 January 2025 1,750 1,750
Additions 401 401
At 31 December 2025 2,151 2,151
Accumulated depreciation
At 01 January 2025 435 435
Charge for the financial year 379 379
At 31 December 2025 814 814
Net book value
At 31 December 2025 1,337 1,337
At 31 December 2024 1,315 1,315

5. Fixed asset investments

2025 2024
£ £
Subsidiary undertakings 8,610 8,610

Investments in subsidiaries

2025
£
Carrying value at 31 December 2025 8,610
Carrying value at 31 December 2024 8,610

6. Debtors

2025 2024
£ £
Trade debtors 11,894 21,498
Amounts owed by Group undertakings 8,272 8,272
Other debtors 907 2,692
21,073 32,462

7. Cash and cash equivalents

2025 2024
£ £
Cash at bank and in hand 55,194 233,604

8. Creditors: amounts falling due within one year

2025 2024
£ £
Other taxation and social security 0 11
Other creditors 3,821 3,488
3,821 3,499

9. Called-up share capital

2025 2024
£ £
Allotted, called-up and fully-paid
1,000,500 Ordinary shares of £ 0.0001 each (2024: 1,000,000 shares of £ 0.0001 each) 100.05 100.00
326,934 Ordinary A shares of £ 0.0001 each (2024: 247,687 shares of £ 0.0001 each) 32.69 24.77
127,483 Ordinary B shares of £ 0.0001 each (2024: nil shares) 12.75 0
145.49 124.77

10. Related party transactions

All related party transactions during the current period, including key management personnel compensation, were made under normal market conditions.

11. Ultimate controlling party

In the opinion of the directors there is no ultimate controlling party.